This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abcam
other brands :
Epitomics, Ascent Scientific, MitoSciences
product type :
antibody
product name :
Anti-TRA-1-60 (R) antibody [TRA-1-60]
catalog :
ab16288
quantity :
10 µl, 100 µl
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
TRA-1-60
reactivity :
African green monkey, human, rhesus macaque
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, radioimmunoassay, immunohistochemistry - frozen section
citations: 35
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:200; loading ...
Liang F, Wang B, Geng J, You G, Fa J, Zhang M, et al. SORBS2 is a genetic factor contributing to cardiac malformation of 4q deletion syndrome patients. elife. 2021;10: pubmed publisher
  • immunocytochemistry; human; 1:500; fig 1c
Sarvestani S, SIGNS S, Hu B, Yeu Y, Feng H, Ni Y, et al. Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity. Nat Commun. 2021;12:262 pubmed publisher
  • immunohistochemistry; human; loading ...; fig s2-1c
Roth J, Muench K, Asokan A, Mallett V, Gai H, Verma Y, et al. 16p11.2 microdeletion imparts transcriptional alterations in human iPSC-derived models of early neural development. elife. 2020;9: pubmed publisher
  • immunocytochemistry; African green monkey; 1:200; loading ...; fig 5b
  • immunocytochemistry; rhesus macaque; 1:200; loading ...; fig 6a
Stauske M, Rodriguez Polo I, Haas W, Knorr D, Borchert T, Streckfuss Bömeke K, et al. Non-Human Primate iPSC Generation, Cultivation, and Cardiac Differentiation under Chemically Defined Conditions. Cells. 2020;9: pubmed publisher
  • immunocytochemistry; human; 1:200; loading ...; fig 2a
Schrank S, McDaid J, Briggs C, Mustaly Kalimi S, Brinks D, Houcek A, et al. Human-Induced Neurons from Presenilin 1 Mutant Patients Model Aspects of Alzheimer's Disease Pathology. Int J Mol Sci. 2020;21: pubmed publisher
  • immunocytochemistry; human; loading ...; fig s3a
Ahfeldt T, Ordureau A, Bell C, Sarrafha L, Sun C, Piccinotti S, et al. Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons. Stem Cell Reports. 2020;14:75-90 pubmed publisher
  • immunocytochemistry; human; 1:100; loading ...; fig 3a
He J, Weng Z, Wu S, Boheler K. Generation of Induced Pluripotent Stem Cells from Patients with COL3A1 Mutations and Differentiation to Smooth Muscle Cells for ECM-Surfaceome Analyses. Methods Mol Biol. 2018;1722:261-302 pubmed publisher
  • immunocytochemistry; human; loading ...; fig 5d
Arioka Y, Ito H, Hirata A, Semi K, Yamada Y, Seishima M. Behavior of leucine-rich repeat-containing G-protein coupled receptor 5-expressing cells in the reprogramming process. Stem Cell Res. 2017;20:1-9 pubmed publisher
  • immunocytochemistry; human; loading ...; fig 2a
Moore J, Loeb D, Hong K, Sorensen P, Triche T, Lee D, et al. Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line. Front Cell Dev Biol. 2015;3:15 pubmed publisher
Zeng S, Yang H, Wang B, Xie Y, Xu K, Liu L, et al. The MORC2 p.S87L mutation reduces proliferation of pluripotent stem cells derived from a patient with the spinal muscular atrophy-like phenotype by inhibiting proliferation-related signaling pathways. Neural Regen Res. 2024;19:205-211 pubmed publisher
Naama M, Rahamim M, Zayat V, Sebban S, Radwan A, Orzech D, et al. Pluripotency-independent induction of human trophoblast stem cells from fibroblasts. Nat Commun. 2023;14:3359 pubmed publisher
Liu X, Qiao J, Jia R, Zhang F, Meng X, Li Y, et al. Allele-specific gene-editing approach for vision loss restoration in RHO-associated retinitis pigmentosa. elife. 2023;12: pubmed publisher
Newman P, Yip Q, Osteil P, Anderson T, Sun J, Kempe D, et al. Programming of Multicellular Patterning with Mechano-Chemically Microstructured Cell Niches. Adv Sci (Weinh). 2023;10:e2204741 pubmed publisher
Oliveira A, Martins S, Cammarata G, Martins M, Cardoso A, Almeida M, et al. Generation and Characterization of Novel iPSC Lines from a Portuguese Family Bearing Heterozygous and Homozygous GRN Mutations. Biomedicines. 2022;10: pubmed publisher
Rakovic A, Voß D, Vulinović F, Meier B, Hellberg A, Nau C, et al. Electrophysiological Properties of Induced Pluripotent Stem Cell-Derived Midbrain Dopaminergic Neurons Correlate With Expression of Tyrosine Hydroxylase. Front Cell Neurosci. 2022;16:817198 pubmed publisher
Vajhøj C, Schmid B, Alik A, Melki R, Fog K, Holst B, et al. Establishment of a human induced pluripotent stem cell neuronal model for identification of modulators of A53T α-synuclein levels and aggregation. PLoS ONE. 2021;16:e0261536 pubmed publisher
Inak G, Rybak Wolf A, Lisowski P, Pentimalli T, Jüttner R, Glažar P, et al. Defective metabolic programming impairs early neuronal morphogenesis in neural cultures and an organoid model of Leigh syndrome. Nat Commun. 2021;12:1929 pubmed publisher
Khabarova A, Pristyazhnyuk I, Orlova P, Nikitina T, Kashevarova A, Lopatkina M, et al. Generation of iPSC line ICGi024-A from human skin fibroblasts of a patient with ring chromosome 18. Stem Cell Res. 2020;49:102076 pubmed publisher
Gridina M, Orlova P, Minina J, Shitik E, Lemskaya N, Grishchenko I, et al. Establishment of an induced pluripotent stem cell line (ICGi026-A) from peripheral blood mononuclear cells of a patient with fragile X syndrome. Stem Cell Res. 2020;49:102070 pubmed publisher
Gridina M, Nikitina T, Orlova P, Minina J, Kashevarova A, Yakovleva Y, et al. Establishment of an induced pluripotent stem cell line (ICGi025-A) from fibroblasts of a patient with 46,XY,r(8)/45,XY,-8 mosaicism. Stem Cell Res. 2020;49:102024 pubmed publisher
Barbuti P, Santos B, Dording C, Cruciani G, Massart F, Hummel A, et al. Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA. Stem Cell Res. 2020;48:101951 pubmed publisher
Gomez Giro G, Arias Fuenzalida J, Jarazo J, Zeuschner D, Ali M, Possemis N, et al. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis. Acta Neuropathol Commun. 2019;7:222 pubmed publisher
DiSalvo M, Smiddy N, Allbritton N. Automated sensing and splitting of stem cell colonies on microraft arrays. APL Bioeng. 2019;3:036106 pubmed publisher
Preisler L, Ben Yosef D, Mayshar Y. Adenomatous Polyposis Coli as a Major Regulator of Human Embryonic Stem Cells Self-Renewal. Stem Cells. 2019;37:1505-1515 pubmed publisher
Nikitina T, Menzorov A, Kashevarova A, Gridina M, Khabarova A, Yakovleva Y, et al. Induced pluripotent stem cell line, IMGTi003-A, derived from skin fibroblasts of an intellectually disabled patient with ring chromosome 13. Stem Cell Res. 2018;33:260-264 pubmed publisher
Baltussen L, Negraes P, Silvestre M, Claxton S, Moeskops M, Christodoulou E, et al. Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics. EMBO J. 2018;37: pubmed publisher
Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti E, et al. Human pluripotent reprogramming with CRISPR activators. Nat Commun. 2018;9:2643 pubmed publisher
Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun. 2018;9:335 pubmed publisher
Yang Y, Wu H, Kang X, Liang Y, Lan T, Li T, et al. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs. Protein Cell. 2018;9:283-297 pubmed publisher
Rodríguez Madoz J, San Jose Eneriz E, Rabal O, Zapata Linares N, Miranda E, Rodriguez S, et al. Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome. PLoS ONE. 2017;12:e0190275 pubmed publisher
Forrest M, Zhang H, Moy W, McGowan H, Leites C, Dionisio L, et al. Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci. Cell Stem Cell. 2017;21:305-318.e8 pubmed publisher
Chen Z, Chang W, Etheridge A, Strickfaden H, Jin Z, Palidwor G, et al. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape. Aging Cell. 2017;16:870-887 pubmed publisher
Mellios N, Feldman D, Sheridan S, Ip J, Kwok S, Amoah S, et al. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling. Mol Psychiatry. 2018;23:1051-1065 pubmed publisher
Trevisan M, Desole G, Costanzi G, Lavezzo E, Palu G, Barzon L. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells. Int J Mol Sci. 2017;18: pubmed publisher
Yan X, Xu N, Meng C, Wang B, Yuan J, Wang C, et al. Generation of induced pluripotent stem cells from human mesenchymal stem cells of parotid gland origin. Am J Transl Res. 2016;8:419-32 pubmed
product information
CatalogNumber :
ab16288
ItemName :
Anti-TRA-1-60 (R) antibody [TRA-1-60]
Category :
Antibody
Host :
Mouse
Clonality :
Monoclonal
Conjugate :
Unconjugated
Clone Name :
TRA-1-60
Size :
10 µl, 100 µl
SpeciesSummary :
Hu, Rb
Application Summary :
Flow Cyt, ICC, ICC/IF, IHC-Fr, IP, RIA, WB
company information
Abcam
Discovery Drive
Cambridge Biomedical Campus
Cambridge
CB20AX
Stefan.Pritchard@abcam.com, eCommerce@abcam.com, Vicky.Yang@abcam.com
https://www.abcam.com
888-7722226
headquarters: UK